针对非小细胞肺癌的向疗法:当代审查
Ahmed Abdelmonem1, Bidhan Bikram Shah2, Mouza Al Shebli2
1International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC.
American journal of clinical oncology
|December 15, 2025
概括
针对非小细胞肺癌 (NSCLC) 的精密药物向特定的遗传突变. 本综述涵盖了关键的改变,像TKIs这样的向疗法,耐药性机制和个性化NSCLC治疗的诊断工具.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- 精密瘤学通过突变驱动的策略彻底改变了NSCLC的治疗方法.
研究的目的:
- 审查NSCLC中临床相关的遗传变化.
- 讨论针对性疗法,耐药性机制和个性化NSCLC治疗的诊断方法.
主要方法:
- 关于NSCLC遗传变异和向治疗的现有证据的文献综述.
- 综合有关FDA批准和新兴药物的信息,耐药性途径和诊断工具.
主要成果:
- 关键的遗传变化包括EGFR突变,ALK重组,ROS1融合,BRAF V600E,MET外因子14跳转,RET/NTRK融合,HER2变化和KRAS G12C.
- 氨酸激酶抑制剂 (TKI) 和其他药物显示出有效性,但耐药性途径需要进一步的策略.
结论:
- 个性化治疗选择以下一代测序 (NGS) 和液体活检为指导.
- 顺序和组合治疗方法对于管理NSCLC至关重要.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
